Joseph Francis Hokello
Bioprospecting for HIV-1 latency reversing agent (prostratin) from indigenous medicinal plants for latency reversal in HIV-1 subtypes A and D in Uganda (HIV-1_AD_LRA study)-PHASE-3
Joseph Francis Hokello

Methodology

Protocol 1: Isolation of resting memory CD4+ T cells from PBMCs. Protocol 2: Ex-vivo efficacy testing of PROVIRID in HIV-1 subtypes A and D. Protocol 3: Phytochemical profiling of PROVIRID using LC-MS and HPLC. Collaborative execution with UVRI, TASO, and DGAL.